Nilox Midi (Nitroxoline)

Nitroxoline chelates essential metal ions like iron and magnesium, which are cofactors for bacterial enzymes. By binding these ions, it disrupts enzymatic activity and bacterial metabolism in the urinary tract, leading to inhibition of bacterial growth and bacterial cell death.

The specific dose and treatment duration of Nilox Midi are determined by the prescribing healthcare professional based on the severity of the infection, patient age, renal function, and other clinical factors. Patients should follow the prescriber’s instructions exactly.

Safety data for nitroxoline in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and only under the guidance of a qualified healthcare provider.

To request Nilox Midi, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with other urinary antiseptics such as trimethoprim‑sulfamethoxazole, nitroxoline offers a distinct mechanism of metal‑ion chelation, which can be advantageous in infections caused by resistant organisms. Choice of therapy depends on local resistance patterns, patient tolerance, and clinician preference.

Nilox Midi should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture and excessive heat. Keep the product out of reach of children and avoid exposing it to direct sunlight.

Nilox Midi is taken orally, usually with a glass of water. The tablet should be swallowed whole and not crushed or chewed unless otherwise directed by a healthcare professional.

Serious risks, although rare, include hepatic dysfunction and severe allergic reactions such as anaphylaxis. Patients should seek immediate medical attention if they experience signs of liver injury (e.g., jaundice, dark urine) or symptoms of a severe allergic response (e.g., rash, swelling, difficulty breathing).

Nilox Midi should be avoided in individuals with a known hypersensitivity to nitroxoline or other quinoline derivatives. Caution is also advised for patients with significant renal or hepatic impairment, and it should be used only under medical supervision in pregnant or breastfeeding women.